Author(s):
Suha A. AL-Fakhar, Saad Hasan Mohammed Ali, Khalil Ismail A. Mohammed, Wifaq M. Ali, Jinan M. Mousa
Email(s):
dr.khalilmohamed19677@gmail.com
DOI:
10.52711/0974-360X.2021.00873 
Address:
Suha A. AL-Fakhar, Saad Hasan Mohammed Ali, Khalil Ismail A. Mohammed, Wifaq M. Ali, Jinan M. Mousa
Clinical Communicable Diseases Research Unit, College of Medicine, University of Baghdad, Baghdad, Iraq.
*Corresponding Author
Published In:
Volume - 14,
Issue - 9,
Year - 2021
ABSTRACT:
Background: Diarrhea is a common problem in patients with hematologic disease and in patients with immuno compromising conditions. Objective: The aim of the study was to evaluate the presence risk factors that leading to acquire infection with Cl. difficile in children infected sever diarrhea in and immuno compromised patients. Material and Methods: The study was performed on freshly collected stool samples among 32 patients (13 females,19 males) with acute diarrheal in children their ages (1.5 months – 1.3 years) admitted to Pediatric Teaching Hospitals and adults admitted to Baghdad Teaching Hospital (patients with low cellular immunity like ALL, AML (20-75years) from April 2017 to April 2019. A questionnaire was completed for each patient name, age, gender, clinical symptoms like fever, diarrhea, constipation and, abdominal pain. The criteria included also, the risk factors that leading to suppression of cellular immunity. Fresh stool samples were tested by immunochromatographic assay for antigenic detection of Clostridium difficile Ag. Results: C. Idifficile antigen was identified only in three stool samples of male their mean ± S.D. was (24.75-24.37) from 32 patients (13 females,19 males) their ages rang (1.5months-75years), seven of them suffered blood malignancies (such as AML, ALL), while 21patients (seven of them babies) suffered from acute diarrhea with different causes (E. histolytica and fungal infections). All patients had fever, flatulence and abdominal patients, while 4 of patients with low cellular immunity. Conclusion: Cl. diffcile antigen present only few number of patients in three stool samples of maleswho suffered from sever diarrhea, or ALL (acute lymphocytic leukemia), or NHL (non-hodgkinse lymphoma).
Cite this article:
Suha A. AL-Fakhar, Saad Hasan Mohammed Ali, Khalil Ismail A. Mohammed, Wifaq M. Ali, Jinan M. Mousa. Detection of Closteridium difficile in patients with Hematological Malignancies: A Stool Based Immunochromatographic study. Research Journal of Pharmacy and Technology. 2021; 14(9):5010-4. doi: 10.52711/0974-360X.2021.00873
Cite(Electronic):
Suha A. AL-Fakhar, Saad Hasan Mohammed Ali, Khalil Ismail A. Mohammed, Wifaq M. Ali, Jinan M. Mousa. Detection of Closteridium difficile in patients with Hematological Malignancies: A Stool Based Immunochromatographic study. Research Journal of Pharmacy and Technology. 2021; 14(9):5010-4. doi: 10.52711/0974-360X.2021.00873 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-9-87
REFERENCES:
1. Benson AB, Ajani JA, Catalano RB, Engelking C, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. Journal of Clinical Oncology.2004; 22(14): 2918-2926. DOI: 10.1200/JCO.2004.04.132
2. Khayr W, Haddad RY, Noor SA. Infections in hematological malignancies. Disease a Month. 2012; 58: 239-249. DOI: 10.1016/j.disamonth.2012.01.001
3. Tae-Geun G, Myung-Gyu C, Myong KB, Chul-Hyun L, et al. Hematologic diseases: high risk of Clostridium difficile associated diarrhea. World J Gastroenterology. 2014; 20(21): 6602–6607. DOI: 10.3748/wjg.v20.i21.6602
4. Allewelt M, Schüler P, Bölcskei PL, Mauch H, Lode H. Ampicillin + sulbactam vs. clindamycin ± cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clinical Microbiology and Infection. 2004; 10(2): 163-170. https://doi.org/10.1111/j.1469-0691.2004.00774.x
5. Gorschlüter M, Glasmacher A, Hahn C, Schakowski F, et al. Clostridium difficile Infection in Patients with Neutropenia;, Clinical Infectious Diseases. 2001; 33(6): 786-791. https://doi.org/10.1086/322616
6. Raines DL, Lopez FA. Clostridium difficile infection in non-HIV-immunocompromised patients and in HIV-infected patients. Current Gastroenterology Reports. 2011; 13(4): 344-350. doi: 10.1007/s11894-011-0196-6.
7. Feasi M. Clostridium difficile colitis in an immunocompromised patient treated with fidaxomicin. Clinical management issue. 2015; 9(1S): https://doi.org/10.7175/cmi.v9i1S.1039.
8. Schaier M, Wendt C, Zeier M, Ritz E. Clostridium difficile diarrhea in the immunosuppressed patient—update on prevention and management. Nephrology Dialysis Transplantation. 2004; 19(10): 2432–2436. https://doi.org/10.1093/ndt/gfh428
9. D’Ostroph AR, So T-Y. Treatment of pediatric Clostridium difficile infection: a review on treatment efficacy and economic value. Infection and Drug Resistance. 2017; 10: 365-375. doi: 10.2147/IDR.S119571.
10. DePestel DD, Aronoff DM. Epidemiology of Clostridium difficile Infection. Journal of Pharmacy Practice. 2013; 26(5): 464-475. https://doi.org/10.1177/0897190013499521
11. Fordtran JS. Colitis due to Clostridium difficile toxins (2006): underdiagnosed, highly virulent, and nosocomial. Proceedings (Baylor University Medical Center). 2006; 19(1): 3–12. DOI: 10.1080/08998280.2006.11928114
12. Rineh A, Kelso MJ, Vatansever F, Tegos GP, Hamblin MR. Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Review of Anti-infective Therapy. 2014; 12(1): 131–150. doi: 10.1586/14787210.2014.866515
13. Olsen MA, Stwalley D, Demo, Dubberke ER. Increasing Age Has Limited Impact on Risk of Clostridium difficile Infection in an Elderly Population. Open Forum Infectious Diseases. 2018; 5(7): ofy160. doi: 10.1093/ofid/ofy160.
14. Allan B. Wolfson, ed. (2005). Harwood-Nuss’ Clinical Practice of Emergency Medicine (4th ed.). p. 400. ISBN 0-7817-5125-X .
15. Natarajan M, Rogers MAM, Bundy J, Micic D, et al. Gender Differences in Non-Toxigenic Clostridium difficile Colonization and Risk of Subsequent C. difficile Infection. Clinical Research and Infectious Diseases. 2015; 2(2): 1017.
16. Gorschlüter M, Glasmacher A, Hahn C, Schakowski F, et al. Clostridium difficile Infection in Patients with Neutropenia. Clinical Infectious Diseases. 2001; 33(6): 786–791. https://doi.org/10.1086/322616
17. Krones E, Högenauer C. Diarrhea in the Immunocompromised Patient. Gastroenterology Clinics. 2012; 41(3): 677–701. DOI: 10.1016/j.gtc.2012.06.009
18. Binion DG. Strategies for Management of Clostridium difficile Infection in Immunosuppressed Patients. Gastroenterology and Hepatology (NY). 2011; 7(11): 750–752).